Clinical trial
PACMAN - PAcing for CardioMyopathies, a EuropeAN Study
NCT00180596 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00180596 |
|---|---|
| Title | PACMAN - PAcing for CardioMyopathies, a EuropeAN Study |
| Official title | Pacing for Cardiomyopathies, a European Study- A Therapy Acceptance Study |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Device |
| Interventions | Contak heart failure devices |
| Enrollment | 262 |
| Start date | Jan 1, 2000 |
| Completion | Sep 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 6, 2016 |
| Countries | Belgium, Germany |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: